Litigation Details for Chemours Company FC, LLC v. Daikin Industries, Ltd. (D. Del. 2017)
✉ Email this page to a colleague
Chemours Company FC, LLC v. Daikin Industries, Ltd. (D. Del. 2017)
Docket | ⤷ Sign Up | Date Filed | 2017-11-08 |
Court | District Court, D. Delaware | Date Terminated | 2022-07-11 |
Cause | 35:271 Patent Infringement | Assigned To | Maryellen Noreika |
Jury Demand | Plaintiff | Referred To | Christopher J. Burke |
Patents | 9,957,232 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Chemours Company FC, LLC v. Daikin Industries, Ltd.
Details for Chemours Company FC, LLC v. Daikin Industries, Ltd. (D. Del. 2017)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2021-12-09 | 243 | Redacted Document | Initial Invalidity Contentions regarding U.S. Patent 9,957,232 filed by Apotex Corp., Apotex…means U.S. Patent No. 8,076,431. K. The terms “Asserted Patents” or “Patents-in-Suit” means… “Related Patent” or “Related Patents” means, with respect to any specific patent or application…applications, parent patents, child applications, or child patents to which the Patents-in-Suit claims priority… I. The term “the ’609 patent” means U.S. Patent No. 7,122,609. J. The | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |